Aliança AMARTE: A Collaborative Network to Improve Oncologic Pediatric Care in Brazil

Luiz Fernando Lopes1,2, Patrícia Loggetto2, André de Oliveira Junior1

  • 1Hospital De Câncer Infantojuvenil De Barretos, Barretos, São Paulo, Brazil.

Pediatric Blood & Cancer
|September 4, 2025
PubMed

Insights

The AMARTE Alliance improved pediatric cancer care in Brazil through collaboration. This network enhanced diagnostics, treatment, and research, despite challenges in sustainable participation and governance.

Area of Science:

  • Pediatric Oncology
  • Health Equity
  • Collaborative Networks

Background:

  • Significant regional disparities in childhood cancer treatment access and survival exist in Brazil.
  • Initiated in 2014 with six hospitals, the AMARTE Alliance expanded to 31 institutions by 2024.
  • The alliance aims to enhance pediatric oncology care quality nationwide.

Purpose of the Study:

  • To establish a collaborative network for pediatric oncology care in Brazil.
  • To address inequalities in diagnostics and treatment across geographic regions.
  • To foster innovation, research, and specialized training in pediatric cancer care.

Main Methods:

  • The AMARTE Alliance operates on four pillars: equalizing diagnostics, standardizing treatment, conducting survival studies, and promoting scientific development.
  • Infrastructure and human resources are supported by Fundação Pio XII and St. Jude Children's Research Hospital.
  • A semestral assessment (SCORE) monitors member progress and engagement using defined indicators.

Main Results:

  • Three engagement reports show progress, with 17 hospitals improving their SCORE.
  • Key achievements include a shared data registry, standardized protocols, regular scientific meetings, and a dedicated fundraising group.
  • The alliance has fostered a collaborative environment for innovation and learning.

Conclusions:

  • The AMARTE Alliance demonstrates the critical role of collaboration in advancing pediatric oncology.
  • Challenges remain in ensuring sustained specialist participation and navigating diverse governance structures.
  • Developing outcome indicators is crucial for evaluating the long-term impact of the alliance.
Abstract

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
128